These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 21586199)

  • 41. Rituximab in treatment of idiopathic glomerulopathy.
    El-Reshaid K; Sallam HT; Hakim AA; Al-Attiyah R
    Saudi J Kidney Dis Transpl; 2012 Sep; 23(5):973-8. PubMed ID: 22982909
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Substitution of methotrexate for cyclophosphamide in Wegener granulomatosis: a 12-year single-practice experience.
    Villa-Forte A; Clark TM; Gomes M; Carey J; Mascha E; Karafa MT; Roberson G; Langford CA; Hoffman GS
    Medicine (Baltimore); 2007 Sep; 86(5):269-277. PubMed ID: 17873756
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Infliximab efficacy and safety against refractory systemic necrotising vasculitides: long-term follow-up of 15 patients.
    Josselin L; Mahr A; Cohen P; Pagnoux C; Guaydier-Souquières G; Hayem G; Job-Deslandre C; Liferman F; Pourrat J; Guillevin L
    Ann Rheum Dis; 2008 Sep; 67(9):1343-6. PubMed ID: 18445626
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rituximab with or without a conventional maintenance agent in the treatment of relapsing granulomatosis with polyangiitis (Wegener's): a retrospective single-center study.
    Azar L; Springer J; Langford CA; Hoffman GS
    Arthritis Rheumatol; 2014 Oct; 66(10):2862-70. PubMed ID: 24943239
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis.
    Guillevin L; Pagnoux C; Karras A; Khouatra C; Aumaître O; Cohen P; Maurier F; Decaux O; Ninet J; Gobert P; Quémeneur T; Blanchard-Delaunay C; Godmer P; Puéchal X; Carron PL; Hatron PY; Limal N; Hamidou M; Ducret M; Daugas E; Papo T; Bonnotte B; Mahr A; Ravaud P; Mouthon L;
    N Engl J Med; 2014 Nov; 371(19):1771-80. PubMed ID: 25372085
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term Outcomes of Rituximab Therapy in Ocular Granulomatosis with Polyangiitis: Impact on Localized and Nonlocalized Disease.
    Joshi L; Tanna A; McAdoo SP; Medjeral-Thomas N; Taylor SR; Sandhu G; Tarzi RM; Pusey CD; Lightman S
    Ophthalmology; 2015 Jun; 122(6):1262-8. PubMed ID: 25745876
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Wegener's granulomatosis with a possible thyroidal involvement.
    Ozdogu H; Boga C; Bolat F; Ertorer ME
    J Natl Med Assoc; 2006 Jun; 98(6):956-8. PubMed ID: 16775921
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Experience with rituximab treatment (monoclonal antibodies to B-lymphocyte CD20 receptors) of Wegener's granulomatosis patients with renal impairment].
    Novikov PI; Krivosheev OG; Semenkova EN
    Ter Arkh; 2011; 83(11):70-6. PubMed ID: 22312891
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term follow-up of different refractory systemic vasculitides treated with rituximab.
    Rees F; Yazdani R; Lanyon P
    Clin Rheumatol; 2011 Sep; 30(9):1241-5. PubMed ID: 21523362
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term outcome of 37 patients with Wegener's granulomatosis with renal involvement.
    Gottenberg JE; Mahr A; Pagnoux C; Cohen P; Mouthon L; Guillevin L;
    Presse Med; 2007 May; 36(5 Pt 1):771-8. PubMed ID: 17416480
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
    Stasi R; Stipa E; Del Poeta G; Amadori S; Newland AC; Provan D
    Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rituximab for refractory Wegener's granulomatosis.
    Antoniu SA
    Expert Opin Investig Drugs; 2006 Sep; 15(9):1115-7. PubMed ID: 16916277
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prolonged treatment of refractory Wegener's granulomatosis with 15-deoxyspergualin: an open study in seven patients.
    Schmitt WH; Birck R; Heinzel PA; Göbel U; Choi M; Warnatz K; Peter HH; van der Woude FJ
    Nephrol Dial Transplant; 2005 Jun; 20(6):1083-92. PubMed ID: 15827051
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patients.
    Charles P; Néel A; Tieulié N; Hot A; Pugnet G; Decaux O; Marie I; Khellaf M; Kahn JE; Karras A; Ziza JM; Deligny C; Tchérakian C; Guillevin L;
    Rheumatology (Oxford); 2014 Mar; 53(3):532-9. PubMed ID: 24282319
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rituximab therapy for chronic and refractory immune thrombocytopenic purpura: a long-term follow-up analysis.
    Garcia-Chavez J; Majluf-Cruz A; Montiel-Cervantes L; Esparza MG; Vela-Ojeda J;
    Ann Hematol; 2007 Dec; 86(12):871-7. PubMed ID: 17874322
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Case of acute, resistant fulminant Wegener's granulomatosis successfully treated by rituximab.
    Ebrahim AK; Loock JW
    J Laryngol Otol; 2013 Apr; 127(4):411-4. PubMed ID: 23480661
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Perianal Crohn Disease after Treatment with Rituximab for Active Granulomatosis with Polyangiitis.
    Fraser D; Boyle S; Amft N
    J Rheumatol; 2016 Dec; 43(12):2199-2200. PubMed ID: 27909145
    [No Abstract]   [Full Text] [Related]  

  • 58. Successful treatment of gynaecological involvement of granulomatosis with polyangiitis (Wegener's granulomatosis) by rituximab.
    Bastone P; Squifflet JL; Marbaix E; Houssiau F
    Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-142-4. PubMed ID: 26016766
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.
    Jones RB; Furuta S; Tervaert JW; Hauser T; Luqmani R; Morgan MD; Peh CA; Savage CO; Segelmark M; Tesar V; van Paassen P; Walsh M; Westman K; Jayne DR;
    Ann Rheum Dis; 2015 Jun; 74(6):1178-82. PubMed ID: 25739829
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of rituximab in limited Wegener's granulomatosis with refractory granulomatous manifestations.
    Seo P; Specks U; Keogh KA
    J Rheumatol; 2008 Oct; 35(10):2017-23. PubMed ID: 18688911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.